Home Visit
Upload
ASCA-IgG Saccharomyces Cerevisiae Serum
No special precautions
Sample Type
Blood
Recommended for
Male, Female
Report
Within 24 Hours
Blood test at Home
NABL & CAP Accredited Labs
Accurate & Quality Test Reports
Trusted by Leading Doctors & Hospitals
Overview
Anti-Saccharomyces Cerevisiae Antibody IgG is associated with immune responses to Saccharomyces cerevisiae, a yeast commonly found in the digestive tract. The ASCA-IgG (Anti-Saccharomyces Cerevisiae Antibody IgG) Serum Test is a diagnostic blood test used to assist in the differentiation of inflammatory bowel diseases (IBD), specifically to distinguish between ulcerative colitis and Crohn's disease. It measures the presence and quantity of ASCA-IgG antibodies, which are often associated with Crohn's disease. Elevated levels of ASCA-IgG antibodies may indicate Crohn's disease.
ASCA-IgG Saccharomyces Cerevisiae Serum Price
Metropolis Healthcare is a leading diagnostics centre and pathology lab in India equipped with the latest state-of-the-art technologies that provides the ASCA-IgG Saccharomyces Cerevisiae Serum with a clear pricing structure.
The ASCA-IgG Saccharomyces Cerevisiae Serum Price in Mumbai is ₹ 2,360 .
We are committed to deliver accurate and quality results from the best labs in India with complete transparency regarding test cost and turnaround time. No matter where you are, we strive to offer patients high-quality service that is affordable and accessible.
Frequently Asked Questions
The ASCA-IgG Serum Test measures the level of Anti-Saccharomyces Cerevisiae Antibody IgG in the blood.
- Distinguishing between ulcerative colitis and Crohn's disease: It helps differentiate between these two forms of IBD, which is crucial for guiding treatment strategies, as management approaches may differ.
- Providing additional diagnostic information: In cases where the clinical presentation of IBD is unclear, the presence of ASCA-IgG antibodies can aid in diagnosis.
- Tailoring treatment: Identifying Crohn's disease through this test can lead to more targeted treatment plans, as it may affect a different part of the gastrointestinal tract than ulcerative colitis.
- When distinguishing between ulcerative colitis and Crohn's disease: Patients with IBD symptoms who require a precise diagnosis to guide treatment.
- In cases of atypical or ambiguous IBD symptoms: When clinical symptoms do not distinctly align with either ulcerative colitis or Crohn's disease.
- Prior to specific treatment choices: Healthcare providers may use this test to confirm the presence of Crohn's disease before prescribing treatments tailored to this condition.
A positive result in the ASCA-IgG Serum Test, indicating elevated levels of these antibodies, suggests a higher likelihood of Crohn's disease.
The ASCA-IgG Serum Test is a standard blood draw. A healthcare provider will collect a sample of the blood, typically from a vein in the arm. After that, a laboratory analyzes the sample.
No specific preparations are required for the ASCA-IgG test. You should, however, follow their healthcare provider's instructions for blood tests.
The ASCA-IgG Serum Test is often used in conjunction with other diagnostic tests for IBD, such as:
- Imaging studies: X-rays, CT scans, or MRI scans to assess the condition of the digestive tract.
- Colonoscopy or sigmoidoscopy: Visual examinations of the colon and rectum to assess inflammation and tissue damage.
- Blood tests: Complete blood count (CBC) and other blood markers to assess inflammation and overall health.
- Anti-Saccharomyces Cerevisiae Antibody IgG Test
- Crohn's Disease Antibody Test
- IgG Antibodies to Saccharomyces Cerevisiae Test
Ratings & Reviews (0)
Why Metropolis?
Metropolis has a team of 200 senior pathologists and over 2000 technicians delivering diagnostic solutions in the areas of routine, semi specialty and super specialty domains like Oncology, Neurology, Gynaecology, Nephrology and many more.
We offer a comprehensive range of 4000+ clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.
WhatsApp